Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01MH037705 | U.S. NIH Grant/Contract | View source | |
| Janssen RIS-USA-67 | |||
| DAHBR AD-P |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Mental Health (NIMH) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will determine the effectiveness of combining antipsychotic medication with Individual Placement and Support (IPS) and group training with the Workplace Fundamentals Module or Brokered Vocational Rehabilitation in facilitating the search for appropriate work or schooling and maintaining work or school activities in people with recent-onset schizophrenia.
The purpose of this protocol is to test, in recent-onset schizophrenia, the efficacy of a rehabilitative intervention that is designed to enhance the search for appropriate work or schooling and to increase ability to maintain work or school activities more successfully. Predictors of work outcome are being assessed in the context of this work rehabilitation and treatment with the second-generation antipsychotic medication, risperidone.
The Developmental Processes in Schizophrenic Disorders project involves an ongoing series of longitudinal follow-through studies of individuals with a recent onset of schizophrenia. The current protocol focuses particularly on processes affecting work outcome in this initial period after onset of schizophrenia, drawing on findings that link cognitive deficits in schizophrenia to functional outcome. The protocol is determining the effects on work outcome of a rehabilitative intervention designed to enhance search for appropriate work or schooling and to increase ability to maintain work or school activities more successfully. All entering patients are placed on a common antipsychotic medication, oral risperidone, and are provided clinical treatment by a psychiatrist and a case manager. Participating patients are randomly assigned to a combination of Individual Placement and Support (IPS) and group training with the Workplace Fundamentals Module or to a Brokered Vocational Rehabilitation Model.
The protocol is examining the predictors of level of work functioning attained in the context of the work-focused intervention and maintenance on risperidone. Potential neurocognitive and environmental predictors of work and social functioning and clinical course are being examined. Aspects of early perceptual processing, allocation of attention, working memory, secondary verbal memory, and conceptual flexibility that are implicated as influences on functional outcome are assessed, as are potential stresses and supportive influences in the environment.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Experimental | Individual Placement and Support Plus Workplace Fundamentals Module |
|
| 2 | Active Comparator | Brokered Vocational Rehabilitation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Individual Placement and Support | Behavioral | Supported education/employment |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Return to regular work or school during 18 month trial (SAS Work Section) | Every 3 months | |
| Maintenance of work/school attendance over 18 months (SAS) | Every 3 months | |
| Quality of work functioning on Work Behavior Inventory | Baseline, 6 months, 18 months |
| Measure | Description | Time Frame |
|---|---|---|
| Cognitive performance on test battery | Baseline, 6 months, 18 months | |
| Exacerbation or relapse of psychotic symptoms (BPRS) | Every 2 weeks | |
| Retention in treatment |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Keith H Nuechterlein, PhD | University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UCLA Neuropsychiatric Institute | Los Angeles | California | 90095-6968 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| Background | Nuechterlein KH, Subotnik KL, Ventura J, Gitlin MF, Green MF, Wallace CJ, Becker DR, Liberman RP, Drake RE, Mintz J. Advances in improving and predicting work outcome in recent-onset schizophrenia. Schizophrenia Bulletin 31(2): 530, 2005. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012559 | Schizophrenia |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D010166 | Palliative Care |
| D018967 | Risperidone |
| ID | Term |
|---|---|
| D005791 | Patient Care |
| D013812 | Therapeutics |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Workplace Fundamentals Module |
| Behavioral |
Group skills training on job/school topics |
|
| Brokered Vocational Rehabilitation | Behavioral | Vocational rehabilitation through traditional separate state-funded agency |
|
| Oral risperidone | Drug | Risperidone, starting target dosage was 6 mg, adjusted to level judged optimal by treating psychiatrist |
|
|
| Skills training group | Behavioral | Group social skills training that did not focus primarily on work situations |
|
| Every 3 months |
| Awareness of illness (SUMD-R) | Entry, 6 months, 18 months |
| D011744 | Pyrimidinones |
| D011743 | Pyrimidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |